The production of fine chemicals by biotransformations.

[1]  Andreas Schmid,et al.  Pilot-scale production of (S)-styrene oxide from styrene by recombinant Escherichia coli synthesizing styrene monooxygenase. , 2002, Biotechnology and bioengineering.

[2]  L. W. Powell,et al.  A Practical and Robust Process to Produce SB-214857, Lotrafiban, ((2S)-7-(4,4‘-Bipiperidinylcarbonyl)-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1, 4-Benzodiazepine-2-acetic Acid) Utilising an Enzymic Resolution as the Final Step , 2002 .

[3]  V. Nagarajan,et al.  Biocatalysis: applications and potentials for the chemical industry. , 2002, Trends in biotechnology.

[4]  R. Heeren,et al.  Bioconversion of N-Butylglucamine to 6-Deoxy-6-butylamino Sorbose by Gluconobacter oxydans , 2002 .

[5]  P. Mullins,et al.  Kinetic Resolution of β-Amino Esters by Acylation Using Immobilized Penicillin Amidohydrolase , 2002 .

[6]  Junhua Tao and,et al.  Development of a Continuous Enzymatic Process for the Preparation of (R)-3-(4-Fluorophenyl)-2-hydroxy Propionic Acid , 2002 .

[7]  J. W. Wong,et al.  Biocatalytic Oxidation of 2-Methylquinoxaline to 2-Quinoxalinecarboxylic Acid , 2002 .

[8]  M. Manzoni,et al.  Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs , 2002, Applied Microbiology and Biotechnology.

[9]  Ramesh N. Patel,et al.  Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances. , 2001, Current opinion in biotechnology.

[10]  Hans-Ulrich Blaser,et al.  Enantioselective catalysis in fine chemicals production. , 2001, Chemical communications.

[11]  A. Bommarius,et al.  The membrane reactor in the fine chemicals industry , 2001 .

[12]  Edgar Voss,et al.  Enzyme-catalyzed processes in pharmaceutical industry , 2001 .

[13]  J J Heijnen,et al.  Influence of the ethanol and glucose supply rate on the rate and enantioselectivity of 3-oxo ester reduction by baker's yeast. , 2001, Biotechnology and bioengineering.

[14]  Ramesh N. Patel,et al.  Enzymatic synthesis of chiral intermediates for Omapatrilat, an antihypertensive drug. , 2001, Biomolecular engineering.

[15]  H. Schoemaker,et al.  Aminoamidase-Catalyzed Preparation and Further Transformations of Enantiopure α-Hydrogen- and α,α-Disubstituted α-Amino Acids , 2001 .

[16]  A. Kiener,et al.  Industrial biocatalysis today and tomorrow , 2001, Nature.

[17]  R. Hanson,et al.  Regioselective enzymatic aminoacylation of lobucavir to give an intermediate for lobucavir prodrug. , 2000, Bioorganic & medicinal chemistry.

[18]  R. Jain,et al.  Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336. , 2000, The Journal of organic chemistry.

[19]  S. Hashimoto,et al.  Whole microbial cell processes for manufacturing amino acids, vitamins or ribonucleotides. , 1999, Current opinion in biotechnology.

[20]  B Schulze,et al.  Biocatalysis for industrial production of fine chemicals. , 1999, Current opinion in biotechnology.

[21]  G J Lye,et al.  Application of in situ product-removal techniques to biocatalytic processes. , 1999, Trends in biotechnology.

[22]  R. Sheldon,et al.  Dynamic kinetic resolution of phenylglycine esters via lipase-catalysed ammonolysis , 1999 .

[23]  Amihay Freeman,et al.  Effect of processing parameters on the feasibility and operational stability of immobilized viable microbial cells , 1998 .

[24]  Andreas S. Bommarius,et al.  Biocatalysis to amino acid-based chiral pharmaceuticals—examples and perspectives , 1998 .

[25]  William R. Strohl,et al.  Biotechnology of antibiotics , 1997 .

[26]  M. Zmijewski,et al.  Large-scale stereoselective enzymatic ketone reduction with in situ product removal via polymeric adsorbent resins , 1997 .

[27]  M. Dawson,et al.  Efficient procedures for the large-scale preparation of (1S,2S)-trans-2-methoxycyclohexanol, a key chiral intermediate in the synthesis of tricyclic β-lactam antibiotics , 1996 .

[28]  W. Haiyan,et al.  Highly stereoselective access to novel 2,2,4-substituted tetrahydrofurans by halocyclization: Practical chemoenzymatic synthesis of Sch 51048, a broad-spectrum orally active antifungal agent , 1995 .

[29]  Li Ws,et al.  Enzymic preparation of (3R‐cis)‐3‐(acetyloxy)‐4‐phenyl‐2‐azetidinone: a taxol side‐chain synthon , 1994, Biotechnology and applied biochemistry.

[30]  W. Wostl,et al.  Large scale preparation of chiral building blocks for the P3 site of renin inhibitors. , 1994, Bioorganic & medicinal chemistry.

[31]  I. Purvis,et al.  Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, lamivudine): a potent anti-HIV agent. , 1993, Enzyme and microbial technology.

[32]  C. Wandrey,et al.  Operational stability of enzymes. Acylase-catalyzed resolution of N-acetyl amino acids to enantiomerically pure L-amino acids. , 1992, Annals of the New York Academy of Sciences.

[33]  C. Wandrey,et al.  Operational Stability of Enzymes , 1992 .

[34]  Ramesh N. Patel,et al.  Enantioselective enzymatic acetylation of racemic [4-[4α,6β (E)]]-6-[4,4-bis(4-fluorophenyl)-3-(1-methyl-1H-tetrazol-5-yl)-1,3-butadienyl]-tetrahydro-4-hydroxy-2H-pyran-2-one , 1992, Applied Microbiology and Biotechnology.

[35]  D. Gygax,et al.  Optimization of a process for the production of (R)-2-hydroxy-4-phenylbutyric acid--an intermediate for inhibitors of angiotensin converting enzyme. , 1992, Journal of biotechnology.

[36]  B. Buckland,et al.  Development of a large‐scale continuous substrate feed process for the biotransformation of simvastatin by Nocardia s.p. , 1991, Biotechnology and bioengineering.

[37]  Lynda B. M. Ellis,et al.  The University of Minnesota Biocatalysis/Biodegradation Database: emphasizing enzymes , 2001, Nucleic Acids Res..

[38]  A. Bruggink Synthesis of β-Lactam Antibiotics , 2001 .

[39]  Gisela Hieber,et al.  Introducing ChiPros: Biocatalytic production of chiral intermediates on a commercial scale , 2001 .

[40]  E. Vroom,et al.  Innovations in cephalosporin and penicillin production : Painting the antibiotics industry green , 2000 .

[41]  D. Cowan Microbial genomes--the untapped resource. , 2000, Trends in biotechnology.

[42]  F. Gualtieri New trends synthetic medicinal chemistry , 2000 .

[43]  Michael C. Flickinger,et al.  encyclopedia of bioprocess technology , 1999 .

[44]  J. Ogawa,et al.  Microbial enzymes: new industrial applications from traditional screening methods. , 1999, Trends in Biotechnology.

[45]  M. Dawson,et al.  CHEMOENZYMATIC PRODUCTION OF THE ANTIVIRAL AGENT EPIVIR , 1997 .

[46]  Kurt Faber,et al.  Biotransformations in Organic Chemistry , 1992 .